Senator Ogilvie, an expert in biotechnology, bio-organic chemistry and genetic engineering has had many scientific accomplishments in his career including the development of the chemistry of the “Gene Machine”, an automated process for the manufacture of DNA. He is also the inventor of Ganciclovir, a drug used worldwide to fight infections that occur when one’s immune system is weakened.
We are truly appreciative for Senator Ogilvie’s commitment and dedication to helping to advance health research and science in Canada. We are most thankful Dr Ogilvie’s research breakthroughs that have improved the lives of Canadians, especially those with rare diseases.
He has been a true friend to our rare disease community and we will miss him dearly.
Pictured (L to R):
Durhane Wong-Rieger, President & CEO, CORD
Senator Kelvin Ogilvie
Maureen Smith, Secretary, CORD
We need your support! Sign the petition for Funding of Spinraza for all Canadian patients affected by Spinal Muscular Atrophy (SMA) Cure SMA Canada, CORD, the Canadian SMA families and our supporters appeal to our provincial health ministers to provide all patients access to the only treatment available for this life threatening disease.
March 21, 2018
Delta Hotels Ottawa City Centre: 101 Lyon Street North, Ottawa
6th Annual Rare Disease Day Awards Gala Join us on Wednesday evening, March 21st, when CORD will host its annual Rare Disease Day Awards Gala. We will recognize those individuals and organizations that have made extraordinary contributions to the Canadian rare disease community over this past year. Cocktail reception at 6:00 pm followed by dinner at 7:00 pm Business or Smart Cocktail Attire Gala Ticket: $195 Patient Gala Ticket: $125 Table of 8: $1500